A research team led by KAIST (The Korea Advanced Institute of Science and Technology) has unveiled a molecular-level mechanism that explains how graphene oxide (GO) can be both strongly antibacterial and yet biocompatible, paving the way for next‑generation hygienic materials that could reduce reliance on conventional antibiotics.
GO has long been studied as a promising biomedical material thanks to its biocompatibility and excellent antibacterial performance, but the origin of these apparently conflicting behaviors has remained controversial. The new work shows that the key lies in the controlled physicochemical and biomimetic features of GO: abundant oxygen functional groups on the GO basal surface drive highly specific interactions with a bacterial‑signature phospholipid, palmitoyloleoylphosphatidylglycerol (POPG), while sparing mammalian cell membranes.
At the core of the study is an artificial cell model that uses vesicular phospholipid assemblies to mimic bacterial and mammalian membranes, combined with detailed spectroscopic analyses to track how GO interacts at the molecular level. By systematically comparing chemically modified GOs with different physical and chemical features, the team clarified that surface oxygen functionalities govern antibacterial activity by forming selective, surface‑to‑surface contacts with POPG, a phospholipid that is selectively present in membranes of various bacterial species, including drug‑resistant strains. This “lock‑and‑target” behavior underpins what the researchers describe as “selective antibacterial action”: GO attaches to and destabilizes only bacterial membranes - much like a magnet that snaps onto specific metals - while leaving human cells essentially untouched.
The oxygen functional groups on the GO surface recognize and bind POPG, a fatty phospholipid component primarily found in bacterial cell membranes and not in mammalian cell membranes. Once bound, the extended, atomically thin GO sheets enable large‑scale membrane disruption across a broad spectrum of bacteria, including drug‑resistant pathogens, by promoting extensive surface contact and physical destabilization of the POPG‑rich bilayer. Because mammalian cells lack this POPG‑rich outer leaflet composition, their membranes experience far weaker interactions with GO, preserving cell integrity and explaining the coexistence of antibacterial efficacy and biocompatibility without the need for traditional, biochemically active antibiotic motifs.
The antibacterial activity of GO was evaluated across multiple material formats - films, nanofibers, and powders - in vivo using infected wound models in mice and, notably, in a porcine model that is histologically similar to human skin. In these models, GO application led to potent suppression of bacterial growth and noticeably accelerated wound closure rates, while inducing minimal blood clotting and inflammatory responses, underscoring its potential as a safe and sustainable antibacterial platform for long‑term use. These animal data provide in‑depth, preclinical‑level characterization that addresses long‑standing inconsistencies in prior GO antibacterial reports by tying performance directly to the defined surface chemistry and POPG‑targeted mechanism.
A promising implementation is GO‑incorporated nanofibers, which translate the molecular‑level selectivity into a flexible, textile‑like architecture suitable for real products. These nanofibers effectively inhibited the growth of various pathogenic and drug‑resistant bacteria in infected wound models, promoting wound healing while maintaining low inflammation, and they retained antimicrobial efficacy even after repeated textile washing cycles—an essential requirement for reusable medical and protective equipment. The high stability of the antibacterial function, combined with the unique, non‑leaching, membrane‑disruption mode of action, distinguishes GO from many conventional pharmaceuticals and positions it as an active component for smart, reusable infection‑control materials rather than a passive barrier.
This molecularly defined antibacterial principle is already migrating from the lab into everyday hygienic products. A graphene antibacterial toothbrush, is commercialized through the original patents of the faculty‑led startup Materials Creation Co., Ltd. In parallel, GrapheneTex - textile materials incorporating this GO mechanism - was adopted in the uniforms of the Taekwondo demonstration team at the 2024 Paris Olympics and is expected to feature in functional sportswear for upcoming international events such as the 2026 Asian Games, showcasing the technology’s readiness for high‑performance apparel and sports applications.
Beyond consumer products, the study points toward a general design rule for GO‑based antibacterial platforms that can be tuned for diverse healthcare environments. Because the target POPG and related bacteria‑specific phospholipids are generically present across many bacterial species, including superbugs resistant to antibiotics, GO materials could serve as a broad‑spectrum yet selective antibacterial layer in next‑generation wound dressings, surgical instruments, masks, and wearable medical textiles, all while helping to curb the repeated overuse of conventional antimicrobial drugs.
Professor Sang Ouk Kim highlighted that “This study is an example of scientifically uncovering why graphene can selectively kill bacteria while remaining safe for the human body,” and emphasized that, by leveraging this principle, applications can extend “beyond safe clothing without harsh chemicals to an infinite range of applications, including wearable devices and medical textile systems”.
The work provides a scientific foundation for GO as a versatile, long‑term antibacterial material platform that aligns with both clinical demands and practical performance in dynamic, real‑world settings.
